10-K: PCMC Faces Going Concern Doubt, Pursues Healthcare Acquisition

Public Company Management Corporation (PCMC) reports substantial doubt about its ability to continue as a going concern, while actively pursuing a merger with a healthcare facilities company.

Summary

• PCMC is a shell company with no revenues, nominal assets, and an accumulated deficit of $5,736,177 as of September 30, 2025.
• The company's primary objective is to locate and consummate a merger or acquisition with a private operating entity.
• Preliminary discussions are underway for a potential business combination with Physicians Capital Management Corporation, a company that acquires and develops healthcare facilities.
• Auditors have expressed substantial doubt about PCMC's ability to continue as a going concern due to recurring losses and negative cash flows from operations.
• The company reported a net loss of $103,817 for the fiscal year ended September 30, 2025, compared to $81,517 in 2024.
• Cash on hand was $234,405 as of September 30, 2025, up from $100,035 in 2024, primarily due to $300,000 in contributed capital from unrelated parties.
• Material weaknesses in internal control over financial reporting were identified, including a lack of written documentation and misclassification of contributed capital, leading to a restatement of 2024 financials.
• PCMC's common stock is subject to 'penny stock' rules and enhanced regulatory scrutiny for shell companies, impacting liquidity and trading.
• The company is dependent on its majority shareholder, Repository Services LLC, and Specialty Capital Lenders LLC for funding its administrative and reporting expenses.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing with a very negative sentiment due to the company's 'shell' status, recurring losses, significant accumulated deficit, auditor's going concern doubt, and identified material weaknesses in internal controls. While pursuing an acquisition is its stated goal, the financial instability and regulatory challenges present substantial risks.

Positives

• The company has entered preliminary discussions for a potential business combination with Physicians Capital Management Corporation, indicating progress in its core objective.
• Cash on hand increased to $234,405 as of September 30, 2025, from $100,035 in 2024, supported by $300,000 in contributed capital.
• The maturity date of the $350,000 note payable to Specialty Capital Lenders LLC was extended to December 31, 2026, providing additional financial flexibility.

Negatives

• The company has an accumulated deficit of $5,736,177 and a working capital deficit of $207,161 as of September 30, 2025.
• Auditors expressed substantial doubt about PCMC's ability to continue as a going concern.
• Net loss increased to $103,817 for FY2025 from $81,517 for FY2024.
• Negative cash flow from operations was $165,630 for FY2025, worsening from $58,731 in FY2024.
• Material weaknesses in internal control over financial reporting were identified, and disclosure controls and procedures were deemed not effective.
• The 2024 financial statements were restated due to unaccrued expenses and misclassification of advances.
• The company has no independent directors, no audit committee, and no Code of Ethics, raising corporate governance concerns.
• PCMC's common stock is classified as 'penny stock' and faces limited liquidity and trading challenges due to regulatory amendments.

Risks

• The company has not clearly identified a definitive target business, and there is no basis for investors to evaluate the merits or risks of any specific target or industry.
• Real estate development projects, the current focus of preliminary negotiations, are subject to risks such as unexpected delays, cost overruns, market volatility, financing difficulties, and regulatory changes.
• Lack of business diversification means the company's success will be entirely dependent on the future performance of a single business if an acquisition is completed.
• Limited ability to evaluate the target business management, as current management may not remain after a business combination.
• Intense competition from other entities with greater financial and human resources for business combination opportunities.
• Dependence on key personnel, specifically Quynh Hoa T. Tran, who is not obligated to devote full-time efforts, potentially causing conflicts of interest and delays.
• Inability to obtain additional financing, if required, to complete a business combination or fund the operations and growth of the target business.
• Present management will most likely not remain after a business combination, leading to a change in control and potential reduction in current shareholders' ownership.
• Financing requirements to fund ongoing reporting obligations under the Exchange Act are dependent on informal agreements with related parties, which may not be sustained.
• The majority shareholder, Repository Services LLC, has significant influence over actions requiring stockholder vote, potentially limiting minority shareholder impact.
• Broad discretion of management in selecting a business combination, without prior evaluation opportunity for investors.
• Registration requirements under the Securities Act and reporting requirements under the Exchange Act may delay or preclude a business combination, increasing costs and affecting security value.
• Risk of being classified as an Investment Company under the Investment Company Act of 1940, leading to significant registration and compliance costs.
• No independent director means actions and expenses incurred by the sole officer/director are not subject to independent review.
• Limited liquidity of common stock and subjection to 'penny stock' rules make it difficult for investors to dispose of shares and may reduce market value.
• Rule 144 unavailability for resale of securities until one year after ceasing to be a shell company and filing all requisite reports.
• Possible issuance of additional securities in connection with new business opportunities will dilute existing shareholders' ownership interests and may adversely affect market price.
• Dividends are unlikely for the foreseeable future as the company has no revenues or cash resources and intends to retain earnings for business operations.

Future Outlook

The company's future outlook is entirely dependent on successfully identifying and consummating a business combination with an operating company. Management anticipates using capital stock, debt, or a combination thereof, which will likely result in significant dilution for current shareholders and a change in control. The company expects to incur $15,000 to $25,000 annually in reporting and administrative costs, which it plans to meet through loans/advances from Repository Services LLC or Specialty Capital Lenders LLC. There is no assurance that a business combination will be completed or that additional financing will be available on acceptable terms.

Management Comments

• Management anticipates that it may be able to participate in only one potential business venture because the Company has nominal assets and limited financial resources.
• Management intends to devote such time as we deem necessary to carry out the Company's affairs.
• The Company believes its management will act in what we believe will be in the best interests of the shareholders.
• The Company will not enter into a transaction with a target business that is affiliated with management or where there is an actual conflict of interest.

Industry Context

StockSavvy.ai notes that PCMC operates as a 'shell company' in a highly regulated environment, seeking to leverage its public listing status for a reverse merger. This strategy is common for private entities looking to access public markets without a traditional IPO. However, recent SEC amendments to Rule 15c2-11 and new SPAC rules have significantly increased regulatory hurdles and disclosure requirements for shell companies, making such transactions more complex and costly. The company's shift in focus towards healthcare facilities and real estate development reflects a broad search for viable operating businesses, a typical characteristic of shell companies that lack a defined industry focus.

Comparison to Industry Standards

• As a shell company with no operations and recurring losses, PCMC does not meet the financial performance standards of established operating companies in any industry.
• Its corporate governance structure, lacking independent directors, an audit committee, and a code of ethics, falls significantly short of best practices for publicly traded companies, particularly those listed on major exchanges like the NYSE or Nasdaq, which typically require a majority of independent directors and robust committee structures.
• The company's reliance on related-party funding for operational expenses is not typical for healthy, revenue-generating public companies, which usually fund operations through internal cash flow or arm's-length financing.
• The 'penny stock' classification and limited trading market on the OTCID Open Market place it far below the liquidity and investor protection standards of companies listed on national exchanges, which have stricter listing requirements and higher trading volumes.

Management Changes

Corporate Governance

Related Party Transactions

• As of September 30, 2025, the company owed Specialty Capital Lenders LLC $350,000 in principal and $94,529 in accrued interest on a promissory note. The maturity date was extended to December 31, 2026.
• As of September 30, 2025, the company owed $4,799 to related parties for funds advanced for general and administrative expenses (down from $45,232 in 2024).
• Related parties were paid consulting fees of $45,670 for the year ended September 30, 2025, and $40,700 for 2024.
• Repository Services LLC, the majority shareholder (70.3% common stock), provides the company's corporate office space on a rent-free basis and informally agreed to pay expenses in the form of unsecured, non-interest bearing advances.
• Specialty Capital Lenders LLC has agreed to provide financial accommodations up to $20,000 at the prevailing interest rate, though no advances have been made under this specific written agreement as of the filing date.
• Repository Services LLC's Manager and control member is Brian Brick, and Ronald J. Stauber is another member. Specialty Capital Lenders LLC's manager and sole member is Ronald J. Stauber. Quynh Hoa T. Tran has no direct or indirect interest in these entities.

Stakeholder Impact

• **Shareholders**: Face significant dilution risk from future equity issuances for a business combination. Current shareholders' investment is at high risk due to the company's going concern doubt, lack of operations, and limited liquidity of common stock. Rule 144 restrictions on resale further limit their ability to exit positions.
• **Employees**: Currently, only one executive officer (Quynh Hoa T. Tran) who is not full-time. No significant impact on employees as there are virtually none.
• **Customers**: No current customers as the company has no operations or revenues.
• **Suppliers**: Limited impact as the company has minimal operational expenses, primarily professional fees, which are largely funded by related parties.
• **Creditors**: Specialty Capital Lenders LLC, a related party, is the primary creditor for the $350,000 note payable. The extension of the note's maturity date provides some relief, but the company's going concern status poses a risk to repayment.

Next Steps

• Locate and consummate a merger or acquisition with a private operating entity.
• Conduct due diligence on potential target businesses, including Physicians Capital Management Corporation and real estate development companies.
• Negotiate and document relevant agreements for a business combination.
• Prepare and file requisite documents pursuant to applicable securities laws for any business combination, including a Securities Act registration statement if required by Rule 145a.
• Remediate identified material weaknesses in internal control over financial reporting.
• Continue to seek interim funding from Repository Services LLC or Specialty Capital Lenders LLC to cover administrative and reporting expenses.

Key Dates

Recommendation

The company is a shell with no operations, recurring losses, and an accumulated deficit of over $5.7 million. Auditors have expressed 'substantial doubt' about its ability to continue as a going concern. Significant internal control weaknesses and a restatement of prior financials highlight severe operational and reporting deficiencies. While it seeks an acquisition, the high regulatory hurdles for shell companies, potential for massive shareholder dilution, and lack of independent governance make it an extremely high-risk investment with little to no fundamental value. The 'penny stock' classification and limited liquidity further exacerbate the risks, making it unsuitable for most investors.

Keywords

Shell Company, Merger and Acquisition, Healthcare Facilities, Real Estate Development, Going Concern, SEC Filing, 10-K, Penny Stock, Corporate Governance, Internal Controls, Financial Restatement, Related Party Transactions, Capital Raise, Regulatory Risk